3D Systems Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

Key Highlights and Investor Insights

ROCK HILL, South Carolina – March 9, 2026: 3D Systems Corporation (“the Company”) has released its financial results for the fourth quarter and full year ended December 31, 2025. The Company’s management provided an in-depth look at its performance, liquidity, non-GAAP measures, and guidance for the first quarter of 2026.

Key Points from the Report

• Revenue: The Company reported \$106.3 million in adjusted revenue for Q4 2025 (Non-GAAP).
• Gross Profit Margin: The gross profit margin for Q4 2025 was 30.8%, compared to 31.0% in Q4 2024. For the full year, the gross profit margin was 37.4%, a robust figure for the industry.
• Net Income (Loss): 3D Systems reported a net loss attributable to the company of \$(255.6) million for 2025, a significant increase in losses compared to the prior year. Diluted loss per share was \$(0.15) for Q4 2025 and \$(0.25) for Q4 2024.
• Adjusted EBITDA: Adjusted EBITDA for Q4 2025 was \$(5.3) million, showing an improvement from \$(19.1) million in Q4 2024. For the full year, Adjusted EBITDA was \$(66.4) million, compared to a larger loss in 2024.
• Operating Expenses: Non-GAAP operating expenses were \$42.5 million for the quarter and \$250.3 million for the year.
• Cash, Cash Equivalents, and Restricted Cash: The Company ended 2025 with \$172.9 million in cash, compared to \$333.1 million at the end of 2024.
• Liquidity: The Company expects to maintain sufficient liquidity into 2026, despite the net cash used in operating activities of \$(87.8) million for 2025.
• Guidance for Q1 2026:
  • Revenue is expected to be in the range of \$91 million to \$94 million.
  • Adjusted EBITDA is projected at \$(5) million to \$(3) million.
• Stock Repurchases: The Company repurchased \$14.96 million of its shares during 2025.
• Borrowings and Debt: The Company took on \$92 million of new borrowings in 2025, but also repaid existing debt and incurred related costs.
• One-Time Items: The Company recognized a one-time \$8.7 million Regenerative Medicine accounting adjustment within its Healthcare Solutions segment in Q4 2024.
• Disposals: Net proceeds from the sale of assets and businesses were a significant source of cash, with \$138.6 million in gains recognized in 2025.
• Asset Impairment Charges: The Company recorded asset impairment charges of \$760,000 in Q4 2025 and \$1.23 million in Q4 2024.

Important Shareholder Information & Price-Sensitive Issues

• Widening Net Loss: The substantial net loss of \$(255.6) million for 2025, coupled with a significant reduction in cash reserves, is a potentially negative signal for investors. This could impact the Company’s valuation and share price.
• Share Buybacks: The Company’s decision to repurchase nearly \$15 million in stock may be interpreted positively by the market, signaling confidence in future prospects.
• First Quarter 2026 Outlook: The Company’s guidance for continued negative Adjusted EBITDA in Q1 2026 suggests ongoing operational challenges, which investors should monitor closely.
• Liquidity and Debt: The decrease in cash and increase in debt may raise concerns about long-term liquidity and leverage, especially if losses continue.
• Goodwill and Legal Uncertainties: The Company notes the inability to provide full GAAP guidance due to unpredictable legal, acquisition, stock compensation, intangible amortization, restructuring, and goodwill impairment expenses. These could result in further volatility.
• Non-GAAP Adjustments: Management emphasizes the use of non-GAAP measures to better assess operational performance, but investors should be aware these exclude material costs and may not reflect all risks.
• Regenerative Medicine Adjustment: The one-time \$8.7 million accounting adjustment in 2024 affects year-over-year comparability and may influence segment performance analysis.

Conference Call and Webcast

The Company will host a conference call and webcast to further discuss these results on March 9, 2026, at 8:30 a.m. Eastern Time. Investors are encouraged to participate for additional insights and Q&A with management.

Forward-Looking Statements

3D Systems has made several forward-looking statements regarding its financial outlook, performance, and market trends. These are subject to various risks and uncertainties—actual results may differ materially from those anticipated.

Conclusion

The 2025 financial results for 3D Systems Corporation highlight both ongoing operational challenges and management’s efforts to stabilize performance through cost controls, asset sales, and share buybacks. The widening net loss, reduced cash position, and ongoing negative guidance for Q1 2026 are material concerns for shareholders and may exert pressure on the share price. However, the Company’s actions to streamline operations and return value to shareholders via buybacks could mitigate some negative sentiment.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with financial advisors before making investment decisions. Forward-looking statements are subject to change and may differ materially from actual results.

View 3D SYSTEMS CORP Historical chart here